![Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases. - Abstract - Europe PMC Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3716117/bin/zac9991017730001.jpg)
Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases. - Abstract - Europe PMC
![Avibactam and Class C β-Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance | Antimicrobial Agents and Chemotherapy Avibactam and Class C β-Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.03057-14/asset/19043ceb-a8cd-44f5-8251-f83ab49364e2/assets/graphic/zac0091432550006.jpeg)
Avibactam and Class C β-Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance | Antimicrobial Agents and Chemotherapy
![Schematic diagram of avibactam inhibition and deacylation pathways of... | Download Scientific Diagram Schematic diagram of avibactam inhibition and deacylation pathways of... | Download Scientific Diagram](https://www.researchgate.net/publication/281583770/figure/fig8/AS:341796514222088@1458502047440/Schematic-diagram-of-avibactam-inhibition-and-deacylation-pathways-of-KPC-2.png)
Schematic diagram of avibactam inhibition and deacylation pathways of... | Download Scientific Diagram
![Molecular insights into avibactam mediated class C β-lactamase inhibition: competition between reverse acylation and hydrolysis through desulfation - Physical Chemistry Chemical Physics (RSC Publishing) DOI:10.1039/C8CP01670D Molecular insights into avibactam mediated class C β-lactamase inhibition: competition between reverse acylation and hydrolysis through desulfation - Physical Chemistry Chemical Physics (RSC Publishing) DOI:10.1039/C8CP01670D](https://pubs.rsc.org/image/article/2018/CP/c8cp01670d/c8cp01670d-f1_hi-res.gif)
Molecular insights into avibactam mediated class C β-lactamase inhibition: competition between reverse acylation and hydrolysis through desulfation - Physical Chemistry Chemical Physics (RSC Publishing) DOI:10.1039/C8CP01670D
![CARIOU Kevin on Twitter: "Very happy to share that our first paper of 2020 is out! A review in @OrgBiomolChem on the synthesis of avibactam and other diazabicyclooctane β-lactamase inhibitors. Congrats to CARIOU Kevin on Twitter: "Very happy to share that our first paper of 2020 is out! A review in @OrgBiomolChem on the synthesis of avibactam and other diazabicyclooctane β-lactamase inhibitors. Congrats to](https://pbs.twimg.com/media/EOPOecoUEAADYzc.jpg)
CARIOU Kevin on Twitter: "Very happy to share that our first paper of 2020 is out! A review in @OrgBiomolChem on the synthesis of avibactam and other diazabicyclooctane β-lactamase inhibitors. Congrats to
![The road to avibactam: the first clinically useful non-β-lactam working somewhat like a β-lactam | Future Medicinal Chemistry The road to avibactam: the first clinically useful non-β-lactam working somewhat like a β-lactam | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc-2016-0078/asset/images/medium/figure8.gif)
The road to avibactam: the first clinically useful non-β-lactam working somewhat like a β-lactam | Future Medicinal Chemistry
![First oral antibiotic booster for four decades could tackle drug resistance | Research | Chemistry World First oral antibiotic booster for four decades could tackle drug resistance | Research | Chemistry World](https://d2cbg94ubxgsnp.cloudfront.net/Pictures/1024x536/6/2/1/139621_JMC_just_accepted_-_Orally_Absorbed_Derivatives_of_the_beta-Lactamase_Inhibitor_Avibactam._Design_of_Novel_Prodrugs_of_Sulfate_Containing_Drugs-3_Fig3.jpg)
First oral antibiotic booster for four decades could tackle drug resistance | Research | Chemistry World
![A theoretical approach for the acylation/deacylation mechanisms of avibactam in the reversible inhibition of KPC-2 | SpringerLink A theoretical approach for the acylation/deacylation mechanisms of avibactam in the reversible inhibition of KPC-2 | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10822-021-00408-3/MediaObjects/10822_2021_408_Sch3_HTML.png)
A theoretical approach for the acylation/deacylation mechanisms of avibactam in the reversible inhibition of KPC-2 | SpringerLink
![Antibiotics | Free Full-Text | The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases Antibiotics | Free Full-Text | The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases](https://www.mdpi.com/antibiotics/antibiotics-10-01012/article_deploy/html/images/antibiotics-10-01012-g001.png)
Antibiotics | Free Full-Text | The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases
![Epidemiology and Mechanisms of Ceftazidime–Avibactam Resistance in Gram-Negative Bacteria - ScienceDirect Epidemiology and Mechanisms of Ceftazidime–Avibactam Resistance in Gram-Negative Bacteria - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2095809921000035-gr1.jpg)
Epidemiology and Mechanisms of Ceftazidime–Avibactam Resistance in Gram-Negative Bacteria - ScienceDirect
![Unexpected Challenges in Treating Multidrug-Resistant Gram-Negative Bacteria: Resistance to Ceftazidime-Avibactam in Archived Isolates of Pseudomonas aeruginosa | Antimicrobial Agents and Chemotherapy Unexpected Challenges in Treating Multidrug-Resistant Gram-Negative Bacteria: Resistance to Ceftazidime-Avibactam in Archived Isolates of Pseudomonas aeruginosa | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.04238-14/asset/4a953489-3d37-4748-b795-8d73925ecd73/assets/graphic/zac0021536880001.jpeg)